January 21, 2015
Genomics England, a wholly owned Department of Health company, has been set up to deliver the latest “big genomics” venture, where 100,000 whole genomes from 75,000 patients and 25,000 genomes of tumors are to be sequenced by 2017. On 22 December 2014, NHS England announced that 11 centers across the country will become designated Genomic Medicine centers to help deliver the targets of this project, focusing on rare diseases, infectious diseases and cancer. This project will require complex statistical analysis of clinical and molecular data. Genomics England plan to use the international system, Decipher, to link clinicians around the world and pool, with patients’ permission, anonymized data to study genotype-phenotype relationships.